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“The emerging new technologies have significantly contributed in the advancements 
in developing new phytopharmaceuticals and food herbs, which are definitely going to alter 
the future outlook of family physicians and common people.  India can play major role in the 
global market for herbals, herbal products, raw materials and isolated phytopharmaceuticals 
because of its extensive flora and fauna, expertise, trained technocrats and great plant 
heritage from Ayurveda and other resources”. 
Natural products including plants, animals and minerals have been the basis of   
treatment of human diseases and have been exploited for human use for thousands of years. 
The most important sources of drugs and drug leads in history, were introduced worldwide as 
drugs can be traced to or were inspired by natural products.1 We were undergoing various 
works in identifying enormous natural resources which can be exploited to produce herbal 
medicines for the treatment of deadly ailments. 
 
Natural products, the word itself begins with nature. Long back even before the 
evolution of modern science, there where diseases and there where cure too. At that age when 
people didn’t know what is science and technology they used to cure diseases by the help of 
‘God’s gift to the earth” that is his surroundings. What we see today is not the surrounding 
what they had at that time. It was pure nature at the beginning. The mixtures and blends what 
they made out of them cured the diseases. In modern world those treatment are named in 
different name like Ayurveda. Natural Products therapy and Homeopathy etc, it all derives 
from the same source, the source called Nature. 
 
In the modern world the life and life style of human beings has changed rapidly. Now 
a day’s the life of a normal human is almost sedentary. The major drawback of the sedentary 
lifestyle is obesity.2 More than 20% of the world’s population is obese. The major reason for 
this is due to the increased intake of Junk foods and oily foods that are supplied in fast-food 
corners. People are lazy to cook food at home. Another major problem what the modern 
world is facing is the Diabetics. Diabetes is almost everywhere, more than 50% of Indian 
population is diabetic. Even though these two diseases are there in the earth from a long time 
we humans are not able to find a permanent cure for both the problem. Today with the 
advanced scientific technology there have been a lot of inventions to counter this problem but 




Allopathic medicine had its birth in the 19th century during the American civil war. It 
was used as tools to give immediate results.3 Hence it was termed as a wonder drug due to its 
immediate healing property. Meantime as per the ancient scripts people used to practice 
natural medicinal treatment from the first century only. The Chinese scripture shows the use 
of herbal medicines much before that. In olden days wounds where used to be healed by 
using a mixture of herbal pastes and herbal mixtures. The Indian herbal treatment method 
was known as Ayurveda, the European method was known as Homeopathy etc. 
 
Today in our age as a result of constant natural exploitation to curb the hunger of 
Human greed we are in the verge of a mere natural disaster. What we see around us today is a 
concrete jungle instead of what it was years back. As the world developed the common health 
related problems became more common. These were not fully cured by scientific medicine 
and needed the gift of nature to be cured. 
 
Today due to deforestation and natural exploitation the earth is in the brink of 
disaster. What we see around us today is a concrete forest built around us by humans. As the 
world developed the common heath related problems become more common which was not 
fully cured by scientific medicine and which needed the gift of nature to be cured. With the 
help of the old natural treatment scriptures, (Ayurveda, Chinese medicines etc) modern 
scientific world was able to rediscover their ancestors curing technique scientifically and 
what followed was an herbal revolution which we are seeing every day. “The specialty of 
herbal medicines is that, it was able to discover and develop the exact active component of a 
Natural medicine which helped in the curing of a disease”. As a result of this invention today 
we are able to find a lot of natural products in the market in the form of Health Supplements 
in the form of food and beverage and various other products.4 
 
The medicinal chemicals used throughout the world were isolated from natural 
sources. These sources include flowering plants, fungi, bacteria, and to a lesser extent, 
animals, especially marine animals. The subfield of organic chemistry that deals with 
isolating and studying chemicals found in nature is called natural products chemistry. 
Methods such as infrared and nuclear magnetic resonance spectroscopy, mass spectrometry, 
and X-ray methods are used to identify the structures of the compounds.5 Laboratory 
synthesis of the compounds from simpler compounds provides confirmation of the structure 
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as well as a laboratory source of the chemicals. For further confirmation of structure, the 
isolated compound was chemically degraded to simpler compounds, which are more easily 
identified. 
 
 Traditional Medicines derived from medicinal plants are used by about 60% of the 
world’s population. Diabetes is an important human ailment affecting many from various 
lives in different countries. In India it is proving to be a major health problem, especially in 
the urban areas. Though there are various approaches to reduce the ill effects of diabetes and 
its secondary complications, herbal formulations are preferred due to lesser side effects and 
low cost. A list of medicinal plants with proven anti-diabetic and related beneficial effects 
and of herbal drugs used in treatment of diabetes is compiled. One of the etiologic factors 
implicated in the development of diabetes and its complications is the damage induced by 
free radicals and hence an anti-diabetic compound with antioxidant properties would be more 
beneficial.6 
 
Despite the ongoing research on synthetic compound, an equally concentrate and 
innovative interest in medicinal plants has ushered in. These natural medicinal substances are 
toxic potentially and produce certain amount of side effects, although treated with utmost 
care and caution. This has enhanced the instinct of all researchers, the world over, in 
formulating new Anti microbial agents and evaluating the efficacy or potentiality of natural 
products in substituting them as the alternatives for chemical (synthetic) antimicrobial 
agents.7 
 
             Herbal drugs are probably the most common source of samples for evaluation in   
high throughout screens of natural products. They have yielded many useful compounds and 
plant-derived ingredients, which are important components of modern phyto pharmaceuticals. 
Today, the global market is floated with herbal preparations. A number of companies, 
including some multinational are entering into the area of herbal medicines.8-10 
 Constituent of the component drug and reasonable mechanism of action to explain the 
therapeutic abilities, the elucidation of which must be a goal of oriental medicine research, 
plant whose constituents are isolated are used in allopathic medicine e.g. Atropine sulphate 
I.P.,Quinine sulphate I.P., Digoxin U.S.P.etc. 
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 The disadvantage of oriental medicine is that the clinical use of drug is empirical and 
has been based on observation from clinical trials without experimental support. On the other 
hand as a great advantage, the efficacy has been already confirmed with humans. The 
development of science of phytopharmaceuticals in the western countries gave an impetus to 
the search for active principles in plants of Indian origin.  
W.H.O GUIDELINES FOR ASSESSMENT OF HERBAL MEDICINES 
Every herbal formulation must be standardized as per WHO guidelines. WHO 
collaborates and assists health ministries in establishing mechanisms for the introduction of 
traditional plant medicines into primary healthcare programmes, in assessing safety and 
efficacy and in ensuring adequate supplies and the quality control of raw and processed 
materials. HI according to WHO guidelines less stringent selection procedures could be 
applied for the screening, chemical analyses, clinical trials and regulatory measures but the 
procedure for pure phytochemicals for quality control should be identical to that for synthetic 
drugs according to WHO guidelines. 
              The World Health Organization (WHO) has recently defined traditional medicine as 
comprising therapeutic practices that have been in existence, often for hundreds of years, 
before the development and spread of modern medicine and are still in use today. The 
traditional preparations comprise medicinal plants, minerals, organic matter etc11.     
The manufacturing procedure and formula including the amount of excipients should 
be described in detail. The method of identification and quantification of the plant material in 
the finished product should be defined. If the identification of an active principle is not 
possible, it should be sufficient to identify a characteristic substance or mixture of substances 
(e.g. chromatographic fingerprint) to ensure consistent quality of the product. According to 
WHO, "Herbal Medicines" should be regarded as, "Finished, labeled medicinal products that 
contain active ingredients aerial or underground parts of plants, or other plant material, or 
combinations thereof, whether in the crude state or as plant preparations. Plant material 
includes juices, gums, fatty oils, essential oils, and any other substance of this nature. Herbal 
medicines may contain excipients in addition to the active ingredients. Medicines containing 
plant material combined with chemically defined active substances, including, isolated 
constituents of plants are considered to be herbal medicines. Exceptionally, in some countries 
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herbal medicines may also contain, by tradition, natural organic or inorganic active 
ingredients which are not of plant origin. 
Multi-component botanical formulations can be standardized with newer techniques 
such as DNA fingerprinting, high pressure thin layer chromatography (HPTLC), liquid 
chromatography and mass spectroscopy. The value of animal testing to establish safety and 
toxicity is not so critical if the botanicals are used in traditional forms. Nevertheless all the 
critical pharmacopoeial tests such as dissolution time, microbial,  pesticide and heavy metals 
contamination etc. must be in accordance with global standards and all the Ayurvedic 
medicine manufacture must be in accordance with current good manufacturing procedures for 
herbs12. 
HERBAL MEDICINE SCENARIO IN INDIA 
The turnover of herbal medicines in India as over  the counter products, ethical and 
classical formulations and have remedies of Ayurveda, Unani and Siddha systems of 
medicine is about $1 billion with a meager export of $ 80 million. 80% of the exports to 
developed countries are of crude drugs and not finished formulations leading to low revenue 
for the country.  The list of medicinal plants exported from India are Aconitum species (root) 
Acorus calamus (rhizome), Adatoda vasica (whole plant), Berberis aristata (root), Cassia 
augustifolia (leaf and pod), Colchicum luteum (rhizome and seed), Hedychium spicatum 
(rhizome), Heradeum candicans (rhizome), Inuia racemose  (rhizome), Juglans reya (husk), 
Juniperus conimunis (fruit), Juniperus macropoda (fruit), Picrorhizn kurroon  (root), 
Plantago ovata (seed and husk), Podophyllum    emodi (rhizome), Pinicn. yanatum (flower, 
root and bark), Rauwolfia serpentina (root). Rheum emodi (rhizome), Saussurea (rhizome), 
Swertia shirayita (whole plant), Valerian- intamansi  (rhizome), Zingiber officinale (rhizome) 
Five of these, i.e. Glycerrhiza glabra, Commiphora mukut, Plantago ovata. Aloe barbadensis 
and Azardica indica are used in modern medicine. Others are used in 52 to 141 herbal 
formulations and Triphala (Terminalia chebula, and Emblica officinalis] along is used in 219 
formulation13. 
              India with its vast area from Kashmir to kanyakumari and varying soils and climatic 
conditions is a large store house of medicine plants, to be aptly called the “botanical garden 
of the world” and has a rich heritage of indigenous drugs from the Ayurvedic items. 
K.M.College	of	Pharmacy,	Madurai	 Page	6	
 
 The classical medicine system Ayurveda is strictly of Indian origin and development 
and it is still widely practised in India. More than 1500 remedial treatment with Indian 
medicine flora have been reported by Sushrata, Charaka and Vegbhatta in Sanskrit. The  
literature contain information about morphological features of many drugs, their geographical 
distribution and optimum condition for growth, the best season for their maximum potency as 
well as toxic properties thus a definite basis exists for investigating these plants for bioactive 
constituents14. 
 The chemical analysis of crude drug helps us determining the action of medicine in 
health and disease. Today’s emphasis of pharmaceutical research and development is on the 
search for the therapeutic substances with specific functions and minimum side effects in 
particular application. The plant derived substances having the advantages of being tools for 
medicine. Many different types of receptors were identified with the help of 
phytoconstituents e.g. muscarinic an active constituent of poisonous mushroom (amantia 
muscarrnia) was used to find both muscarinic & nicotinic receptors. 
 The natural plant product often serves as chemical models or templates for the design 
and total synthesis of new drug entities, e.g. new drug can be designed with the help of 
phytoconstituent, e.g. from morphine more than 25 synthetic congeners have been derived. 
 The wonder drugs of plant reported in recent years are ginsensosides from panax 
ginseng and have acquired commercial significance in view of its aphrodisiac and general 
tonic properties. 
 During the past decade investigation on secondary plants constituents have made 
phenomenal plant constituents have made phenomenal advances and thanks to the 
development of efficient separation techniques like column, thin layer, high pressure liquid 
and gas chromatography as well as sensitive methods of instrumental analysis such as UV, 
IR, NMR, ESR, ORD, CD and mass spectroscopy. 
 Modern instrumentation techniques have also made feasible, the study of micro 
quantities of substances with considerable precision in determining their chemical structure 
and distribution patterns in plants. 
 Recent reviews and book high light such investigation on the chemistry of medicinal 




 The technology involved in the extraction of pharmaceutical significance in majority 
of the cases is the guarded secret of the pharmaceutical or chemical firm. The method of 
extraction of phytopharmaceuticals represent the co-ordination of research work carried out 
by scientist different disciplines with the advancement in analytical and instrumentation 
technology, it has been possible to devise commercially feasible techniques for extraction of 
several phytochemicals15. 
 The future of phytopharmaceuticals is bright as it undoubtedly serves as a cheep and 




































REVIEW OF LITERATURE 
Mekap et al.,16 investigated for its antiurolithiatic activity in two conventional models 
(in vivo) of Urolithiasis in rats. The two methods chosen were lactose (30%) + ethylene 
glycol (1%) and ammonium chloride (2%) + ethylene glycol (0.75%) induced urolithiasis, 
respectively. The ethanol extract (400 mg/kg bw) reduced the elevated levels of serum 
calcium (3.25 ± 0.30) and urine calcium (2.33 ± 0.18) significantly employing lactose (30%) 
+ ethylene glycol (1%) induced urolithiasis model. The ethanol extract (400 mg/kg bw) 
reduced the urine uric acid level significantly employing both models, viz. lactose (30%) + 
ethylene glycol (1%) (0.82 ± 0.07; 0.001) and ammonium chloride (2%) + ethylene glycol 
(0.75%) (0.85 ± 0.12; 0.001) when compared to toxic group. The ethanol extract (400 mg/kg 
bw) employing both models resulted in reduced serum creatinine and calcium, urine oxalate 
and kidney weight significantly with a marked increase in final body weight and urine 
volume output when compared to toxic group. The results shown by the ethanol extract (400 
mg/kg bw) group was compared to standard polyherbal drug (Cystone; 5 ml/kg bw) treated 
group and thus exhibited potent antiurolithiatic activity. 
Amaresh Panda et al.,17 designed to conduct phytochemical screening of Crataeva 
magna leaves after each successive extraction with petroleum ether, chloroform, methanol 
and water followed by its hepatoprotective activity study. Three different types of models 
used to examine the in vivo hepatoprotective activity of the above said extract were carbon 
tetrachloride, ethanol and paracetamol induced hepatotoxicity in rats and compared with 
silymarin (20 mg/kg) as reference standard. Phytochemical screening revealed the presence 
of carbohydrates, phenolic compounds, tannins, flavonoids, saponins and fixed oils in the 
aqueous extract of the Crataeva magna leaves. Two way analysis of variance study of the 
estimated biochemical parameters to illustrate, aspartate aminotransferase, alanine amino 
transferase and alkaline phosphatase were revealed that there is significant difference           
(p-value < 0.001) exists between the different treatment groups. Severe hepatic lesions 
induced by carbon tetrachloride, ethanol and paracetamol were significantly lowered after the 
administration of CM 200 mg/kg to the respective control groups (carbon tetrachloride > 










































Solomon Kiruba et al.,18 studied it could serve as a pilot for the development of  
novel agents for various  pathological disorders. However less information available  
regarding chemical constituents and bioactivity of this ethanomedicinally important species. 
Preliminary phytochemical screening of the pericarp of Crataeva magna proved the presence 
of phytochemicals such as phenols,saponins and tannins. 
Monnanda Nalini et al.,19 isolated Fungal endophytes from Crataeva magna, a 
medicinal plant growing along the streams and rivers, constituting riparian vegetation in 
Karnataka, southern India. Fresh bark and twig pieces were used for the isolation using 
standard methods. Ninety-six endophytic fungal isolates were isolated from 800 bark and 
twig segments. Mitosporic fungi represented as a major group (85%) followed by 
zygomycetes (10%) and ascomycetes (5%). Bark samples contained more endophytes than 
twig samples. Verticillium, Nigrospora oryzae and Fusarium verticilloides were the dominant 
fungal endophytes.   
Bopana et al.,20 developed of an efficient micropropagation protocol will play a 
significant role in meeting the requirement of quality planting material for commercial 
cultivation thereby conserving the species in its natural habitat. In the present study, shoot 
multiplication was achieved by culturing single node segments derived from a field grown 
tree on Murashige and Skoog's (MS) medium supplemented with 2.66 μM N6-benzyladenine, 
1.39 μM Kinetin (Kn), 0.57 μM indole-3-acetic acid (IAA), 3% sucrose and 0.2% gelrite. 
96% rooting was achieved within 22 days by culturing the in vitro formed shoots on half 
strength MS medium with 11.42 μM IAA, 9.8 μM indole-3-butyric acid, 0.46 μM Kn and 
198.25 μM phloroglucinol. Following a simple hardening procedure involving sequential 
transfer of plants to a greenhouse, polyhouse, and shade net, the tissue-cultured plants were 
transferred to the field where the survival rate was 100%. To this date 500 plants have been 
produced. Inter simple sequence repeat analysis has confirmed genetic uniformity of the 
tissue-cultured plants. 
Sovan Pattanaik et al.,21 studied Crataeva magna, and Euphorbia nerifolia have been 
shown to possess hepatoprotective activity and antioxidant property. The plants were 
undertaken with the premise that the drug promoting hepatoprotective activity and radical 
scavenging property could have effect on wound healing also. The wound healing property of 
the methanolic extract of the leaves of Crataeva magna (CNM) and Euphorbia nerifolia 
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(ENM) were chosen to investigate in excision and incision wound models. The methanolic 
extracts of the two plants at the dose of 500 mg/kg/day by topically applying method. Healing 
was assessed by the rate of wound contraction, time until complete epithelialization, incision 
breaking strength, estimation of hydroxyproline and histopathological parameters. Complete 
wound contraction was shown by both the plants in the study period. In excision and incision 
wound models, all the test drugs showed significant (P<0.001) wound healing activities 
compared to the control. Moreover the CNM was found to possess significant wound healing 
activities than the ENM and had been observed to have equipotent wound healing activity as 
of the standard drug Framycetin. 
Nataraj Loganayaki et al.,22 investigated leaf and stem bark of Crataeva magna are 
evaluated for their antioxidant activity and inhibition of key enzymes relevant to 
hyperglycemia. Both the parts exhibited significant antioxidant and anti-α-glucosidase 
activity. The results will lead in favor of the use of this plant as a potential 
additive/nutraceutical antioxidant compound. 
Gagandeep et al.,23 investigated Crataeva nurvala leaves resulted in the isolation of 
four compounds, which are dodecanoic anhydride, methyl pentacosanoate, kaemferol-3-O-α-
D-glucoside and quercitin-3-O-α-D-glucoside. Dodecanoic anhydride and methyl 
pentacosanoate are being reported for the first time from this plant. Kaemferol-3-O-α-D-
glucoside and quercitin-3-O-α-D-glucoside have already been reported from this plant. 
Evaluation of free radical scavenging activity, wound healing activity and estimation of 
phenolic, flavonoid and proanthocyanidine contents of the plant “Crataeva magna”. 
Pattanaik et al.,24 reported to prevent occurrence of many inflammatory and 
metabolic disorders. Pharmacological evaluation of Crataeva magna has revealed its potent 
activity against many diseases. This study evaluates the antioxidant capacity and wound 
healing activity of three extracts (petroleum ether,chloroform, methanol) were assessed 
against in vitro free radical scavenging activity by ABTS method, DPPH method and total 
ferric reductive potential and in vivo wound healing potential in rats respectively, suggesting 
its role as bioactive enhancer. The all three extract have antioxidant and wound healing 
activity, but the methanolic extract showed greater and pet ether extract showed the minimum 
free radical scavenging and wound healing activity. The methanolic extracts of the plant 
Crataeva magna  posses higher phenolic, flavonoid and proanthocyanidine content than the 
other chloroform and pet ether extract. 
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Loganayaki et al.,25 investigated leaf and stem bark of Crataeva magna are evaluated 
for their antioxidant activity and inhibition of key enzymes relevant to hyperglycemia. Both 
the parts exhibited significant antioxidant and anti-α-glucosidase activity. The results will 
lead in favor of the use of this plant as a potential additive/nutraceutical antioxidant 
compound. 
 
Babu et al., 26 evaluated the hepatoprotective activity of ethyl acetate extract of stem 
bark of Crataeva magna (cm) in CCl4 induced toxicity in wistar albino rats. Stem bark of cm 
were collected, and subjected to continuous hot extraction in a soxhlet apparatus, for 72 h 
with solvents like chloroform, ethyl acetate and distilled water separately. Liver damage was 
induced in rats by administering CCl4 subcutaneously (s.c) In the lower abdomen in a 
suspension of liquid paraffin (lp) in the ratio 1: 2 v/v at the dose of 1 ml CCl4/kg b. Wt of 
each animal. CCl4 was administered twice a week, on every first and fourth day of all 14 
days. The extract at the dose of 200 mg/kg and 400 mg/kg b. Wt. Was evaluated by inducing 
hepatotoxicity with CCl4 and using silymarin (100 mg/kg) as the reference standard. 
Biochemical parameters like, sgot, sgpt, salp and serum bilirubin level were analysed. The 
ethyl acetate extract of Crataeva magna possess significant hepatoprotection against CCl4 
induced hepatotoxicity in albino rats. 
 
Chadathorn Inyai et al.,27 investigate new pancreatic lipase inhibitor from Crataeva 
magna (Kum-nam). The ethanolic extract of Kum-nam was screened for anti-lipase activity 
by using porcine pancreatic lipase assay. p-nitrophenylbutyrate was used as the substrate. It 
was found that, Crataeva magna extract showed an anti-lipase activity with the IC50 of 
801.17µg/mL, while IC50 of Orlistat, positive control was 0.68µg/mL. The anti-lipase activity 
mechanism was mixed inhibition. Although, anti-lipase activity of Kum-nam was lower than 
Orlistat, further study of this plant should be conducted. 
Jerajani et al.,28 described that Purim tablet is a polyherbal formulation indicated for 
management of chronic dermatitis and it contains extracts of Curcuma longa, Cassia fistula, 
Psoralea corylifolia, Saussurea lappa, Picrorhiza kurroa, Azadirachta indica, Tinospora 
cordifolia, Crataeva magna, Eclipta alba, Andrographis paniculata, Emblica ribes, Emblica 
officinale, Terminalia chebula and Terminalia belerica. This study was planned to evaluate 
efficacy and safety of Purim tablet in chronic dermatitis. Aatopic dermatitis is an expression 
of immunologic malfunction, which manifests as a spectrum of complicated clinical 
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manifestations. This clinical trial observed highly significant rapid symptomatic relief and 
clinical improvement, with Purim tablets and there were no reported or observed adverse 
events. This study concluded that Purim tablets were clinically highly effective and safe in all 
types of chronic dermatitis. 
          Enamul Haque et al.,29 evaluated that two triterpenoids, phragmalin triacetate (1) and 
lupeol (2) were isolated from an ethyl acetate extract of the stem bark of Crataeva nurvala 
(Capparidaceae) by repeated chromatography over silica gel. The structures of these 
compounds were determined by spectroscopic analyses (UV, IR, 1HNMR, 13C NMR and 
EIMS). This is the first report of the systematic phytochemical investigation and the presence 
of these compounds 1 and 2 from this plant. 
 
Prabhat Das et al.,30 evaluated the effect of Crataeva magna, whole plant (ethanolic 
and aqueous extract p.o.) on alloxan induced diabetes in appropriate animal model. The study 
was carried out on alloxan induced diabetic model. The diabetes was induced by using 
Alloxan and Glibencamide (5 mg/kg) was used as standard drug. The aqueous extract of 
leaves of Crataeva magna, results maximum yield value than that of petroleum ether extract, 
chloroform extract and alcohol extract through successive maceration process. The aqueous 
extract of leaves of Crataeva magna showed maximum control of blood sugar in 
hyperglycemic Wistar rats than other experimental extracts. The test extract also reduces the 
blood sugar level to a maximum extent in case of normal animals. So we finally came to the 
conclusion that the plant Crataeva magna increases healing of diabetes and prevents the 
development of experimentally induced diabetes in Wistar rats. 
Sathya et al.,31 standardized the physico-chemical traits of the Siddha polyherbal 
formulation Maavilingathy Mathirai (MLM). The organoleptic characters, physico-chemical 
characters like ash values, pH value, specific gravity, solubility were analyzed. The total ash 
value was found to be 9.2% w/w, acid insoluble ash value is 1.08% w/w, water soluble ash 
value is 2.9 %w/w, and loss of drying at 105ºC is 0.048 % w/w. The pH value is 7.4 and 
specific gravity is 0.925. The water soluble extractives and alcohol soluble extractives were 
found to be 7.93% w/w and 5.16 % w/w. The SEM analysis of the sample showed the 
presence of nano and micro particles. The quantitative analysis of the sample revealed the 
content of carbon, oxygen, magnesium, aluminium, silica, sulphur, chloride, potassium, 
calcium. The FT-IR spectroscopy applied in the mid infra-red region 4000 cm-1 to 400cm1 
revealed the presence of functional groups like primary aliphatic amines, aromatics, alkanes, 
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alkynes, esters, ethers, alkyl halides. This study highlights the suitable application of modern 
standardizing techniques for bringing the herbal formulation into focus. 
Atanu Bhattacharjee et al.,32 Crataeva nurvala Buch-Hum (Varuna) is well known 
traditional Indian medicinal plant used to treat various ailments in particular urolithiasis. 
During last two decades, numerous ethno- pharmacological and scientific reports have been 
cited in the literature to support its multi- directional therapeutic potential. The plant is rich in 
alkaloids, saponins, triterpenes, tannins, flavanoid glycosides, glucosinolates and 
phytosterols. The review emphasizes primarily on folkloric uses, biological activities of 
isolated compounds, pharmacological activities of the extracts, clinical studies and safety 
profile of Crataeva nurvala to provide a comprehensive data for researchers to hit upon new 
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AIM AND SCOPE OF PRESENT STUDY 
 
In view of the various Phyto constituents and Pharmacological properties of the plant 
Crataeva magna Lour (DC), it was decided to work on the root bark which is used as 
indigenous medicine. The aim of the dissertation work was divided into the following areas 
 
 Preparation of crude extracts by Hot percolation method using various solvents of 
increasing polarity. 
 
 Preliminary screening of crude extracts obtained after solvent extraction and partial 
purification by Thin Layer Chromatography and Phyto chemical test analysis. 
 
 Isolation and purification of selective phyto constituents by column chromatography. 
 
 Characterization of the purified compounds by spectral methods. 
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MORPHOLOGICAL STUDY OF Crataeva magna Lour (DC)  
 
 LATIN BINOMIAL 
 
 Botanical Name        : Crataeva magna Lour (DC) 
 Family                      :  Capparaceae 
  
 VERNACULAR NAMES 
 
 Bengali : Tikoshak 
 Gujarati :   Vayavarna 
 Hindi : Barna 
 Kannada : Narmbele,Varuna 
 Malayalam : Nirvala 
          English                    : Three lived caper 
 Tamil : Maralingam 
 Telugu : Uskia 
 
ETHANOMEDICAL PROPERTIES AND USES 
 
ROOT:   The root of the plant have been used in Skin diseases, Astringent, Anthelmintic,     
Purgative, Emetic Diaphoretic, Antipyretic and Anti – tubercular properties. Root 
bark is an antidote for several poisons. Root bark is very bitter and is reputed as a 
cure for skin diseases33. 
STEM:  The stem bark of the plant exerts a biphasic action and possesses marked 
hypotension in higher dose. 
LEAF:    The leaves of the plant was used as Anti - protozoa,  Hypoglycemic, Spasmolytic. 
                The leaves are applied as poultice in rheumatism. 
FRUIT:  Fruits are sweet, cooling, and purgative and used as a poultice for treating burning            






MORPHOLOGICAL CHARACTERS OF Crataeva magna Lour DC 
 
           A small tree growing upto10m height with wide spreading branches widely found in 
sub Himalayan tracts extending eastwards to Bihar, North Bengal, the hills of Assam, 
Meghalaya and Arunachal Pradesh and distributed throughout India34. 
 
           Strong root yellow in colour with brown bark ; stem bark is pale brown coloured with 
shallow cracks, young parts pubescent ; leaves smooth,  broad-ovate, entire to sub quadrate 
with large lobes ; flowers cream coloured or white in dense cymes; berries dark purple when 
ripe, ovoid; seeds slightly grooved, black on both faces with lateral white band. 
 
          The stem bark and leaves were collected at Tirunelveli District. 
 
HABITAT AND DISTRIBUTION 
 
          The Crataeva magna Lour DC belongs to the family Capparaceae .A genus of shrubs 
or small trees, distributed in the Indo-Malaysian region, China, eastern Australia and tropical 
Africa. Four species occur in India35. 
 
         A small tree, with spreading branches, found in the sub-Himalayan tracts and Kumaun, 
extending eastwards to Bihar, North Bengal, Hills of Assam, Meghalaya, Manipur and 
Arunachal Pradesh. 
 
        The tree occurs generally in moist ravines and is occasionally grown for hedges. It 
grows moderately fast. It is one of the recorded hosts of the Indian lac-insect in Assam. The 
leaves are lopped for fodder36. 
 
         COLLECTION OF PLANT MATERIAL 
 
        The details regarding the description and identification of plant Crataeva magna Lour 
DC were already given. The plant Crataeva magna Lour DC was collected from Tirunelveli 
during the month of May. Then was identified by V.Chelladurai (Reasearch officer, 
Department of Botany, Central council for research in ayurvedha and siddha, Government of 
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India).The root bark were dried in shade for 45 days. Then about 3 kg of the shade root bark 
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PHYTOCHEMICAL INVESTIGATION OF THE ROOT EXTRACT OF   
Crataeva magna Lour (DC) 
           Preparationof root bark extract using different solvents of increasing Polarity. 
Screening    for the detection of various plant   constituent on the following  
SOLVENT EXTRACTION (HOT PERCOLATION METHOD) 
Material used where R.B flask condenser, Petroleum ether AR, Ethanol AR and shade 
dried root bark of Crataeva magna Lour DC39. 
METHOD  
The root bark of Crataeva magna Lour DC where dried in the shade then the shade 
dried root bark where powdered to get a coarse powder. About 350 gms of dried course 
granules of Crataeva magna Lour DC root bark was soaked into 4 litres. Petroleum ether for 
2 days, then it was extract first with petroleum ether at 40 – 60ºC by continuous hot 
percolation method using R.B flask apparatus. The extraction was continued for 72 hours. 
The petroleum ether extract was filtered and concentrated to a dry mass by distillation        
(16 gm) a dark blackish green residue was obtained. The marc left, after petroleum ether 
extraction was taken and then subsequently extract with Chloroform and ethanol for 72 hours. 
The ethanolic extract was taken and the filtered and concentrated to the dry mass. A dark 
brown residue was obtained (20 gms). 
The extract above obtained named as 
 Petroleum ether extract  
 Chloroform extract 







FLOW CHART OF VARIOUS EXTRACTION AND  
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QUALITATIVE CHEMICAL EVALUATION40-42 
        The extracts obtained by the above methods were subjected to qualitative test for the 
identification of various plant constituents. 
 
DETECTION OF CARBOHYDRATES 
        Small quantities of different extracts were dissolved separately in 5 ml of distilled water 
and filtered. The filtrate was subjected to Molish’s test and Fehling’s test to detect the 
presence of carbohydrates. 
 
a) Molish’s test: 
To the filtrate 2-3 drops of 1% alcoholic alpha naphthol and 2 ml of concentrated 
sulphuric acid was added along the sides of test tube. A purple colour ring was formed at the 
junction of the two liquids in Ethanol, chloroform, Aqueous extracts. No purple ring was 
formed in Pet ether extract. It showed negative response for Pet ether extracts for the 
presence of carbohydrates. 
 
b) Fehling’s test : 
      Small portion of various extracts were treated with Fehling’s solution 1 and 2 and then 
heated. A red precipitate was seen in chloroform, Aqueous extracts, Ethanol extracts. No red 
precipitate was seen in Pet ether extract. 
 
DETECTION OF GLYCOSIDES 
      Small quantity of various extracts were hydrolyzed with hydrochloric acid for two hours 
on a water bath and the hydrolysate was subjected to 
 
a) Legal’s  and  b) Borntrager’s  test to detect the presence of different glycosides. 
 
a) Legal’s test: 
             To the hydrolysate extract, 1 ml of pyridine and few drops of sodium 
nitroprusside solution were added then it was made alkaline with sodium hydroxide 
solution. Appearance of pink to yellow colour was observed, it showed the presence of 





b) Borntrager’s test: 
Hydrlosate extract was treated with chloroform and chloroform layer was 
separated. To this equal quantity of dilute ammonia solution was added. Appearance of 
pink colour was observed in ammoniacal layer in all the extracts. 
 
c) Modified Borntrager’s test: 
      The extracts were boiled with few ml of dilute hydrochloric acid and 5 ml of ferric 
chloride solution. The contents are cooled and shaken with organic solvents. Organic 
layer was separated and to this equal volume of ammoniacal solution was added. The 
ammoniacal layer showed pink colour in all the extracts. In this test, addition of ferric 
chloride was added to break the C-C linking of glycosides which is stronger than C=O 
linkage. 
 
DETECTION OF ALKALOIDS  
     Small quantity of extracts were separately treated with a few drops of dilute 
hydrochloric acid and filtered. The filtrate was treated with various alkaloids reagents 
such as  a) Wagner’s reagent  b)  Dragendroff’s reagent  c) Mayer’s reagent and 
      d) Hager’s reagent.  
 
a) Wagner’s reagent: 
To 1 ml of the filtrate few drops of Wagner’s reagent, was added. Reddish brown      
precipitate produced in all the four extracts, indicating the presence of alkaloids.  
  
b) Dragendroff’s test: 
To 1 ml the filtrate few drops of  Dragendroff’s reagent was added Orange red 
precipitate produced in all the four extracts, indicating the presence of alkaloids. 
 
c) Mayer’s test: 
To 1 ml of the filtrate few drops of Mayer’s reagent was added. Cream precipitate 







d) Hager’s test:       
To 1 ml of the filtrate few drops of Hager’s reagent was added.Yellow precipitate   
produced in both Petroleum ether and ethanol extracts indicating the presence of 
alkaloids. No Yellow precipitate produced in   Chloroform and aqueous extracts. 
 
DETECTION OF PHYTOSTEROLS 
    Small quantity of various extracts was dissolved in 5 ml of chloroform separately. 
Then these chloroform solutions were subjected to a) Salkowski test b) Libermann -
Burchard’s test, for the detection of phytosterols. 
 
a) Salkowski test: 
To 1 ml of the above prepared chloroform solution, few drops of concentrated    
sulphuric acid was added and allowed to stand after shaking. chloroform and 
ethanol extract produced red colour in the lower layer. It showed the presence of 
phytosterols. 
 
b) Libermann – Burchard test: 
The above chloroform solution was treated with few drops of acetic anhydride and 
1ml of concentrated sulphuric acid along the sides of the test tube and allowed to 
stand. Green colour was produced chloroform and ethanolic extract indicating the 
presence of phytosterols. 
 
DETECTION OF SAPONINS 
Small quantities of extracts were diluted with 20 ml of distilled water and it was 
agitated in a graduated cylinder for 15 minutes. A 1 cm layer of foam was produced in all the 
four extracts indicating the presence of saponins. 
 
DETECTION OF FIXED OILS AND FATS 
a. Small quantity of various extracts was separated between two filter papers. Oil stains 
were not produced, which showed the absence of fixed oils. 
b. Few drops of 0.5 N alcoholic potassium hydroxide was added to various extracts with 
a few drops of phenolphthalein. The mixture was heated on a water bath for about 2 




DETECTION OF TANNINS 
All the extracts were dissolved separately in minimum amount of water and filtered.  
a) Gelatin test: 
          To the filtrate added 1 ml of 1% solution of gelatin. White precipitate was observed 
in Pet ether; chloroform Extracts indicating the presence of tannins. 
 
b) Ferric chloride test: 
   To the filtrate few drops of ferric chloride solution were added. Bluish black 
precipitate was produced in Pet ether and Chloroform extracts indicating the presence of 
tannins. 
 
DETECTION OF PROTEINS AND AMINOACIDS 
  Small quantities of the different extracts were dissolved in few ml of water and they    
were subjected to  a) Millon’s test  b) Biuret test  c) Ninhydrin test. 
 
a) Millon’s Test : 
The above extracts were treated with Millon’s reagent. Pet ether and chloroform 
extracts produced white precipitate which turns red on heating. 
 
b) Biuret Test : 
The above extracts were warmed gently with equal volume of 10% sodium   
hydroxide and few drops of 1% copper sulphate were added.Reddish violet colour 
was produced in Pet Ether and chloroform extracts . 
 
C) Ninhydrin Test: 
The above extracts were treated with Ninhydrin reagent. No blue or pink colour was 
produced in Aqueous and alcohol extracts. Pet ether and chloroform extract 









DETECTION OF FLAVONOIDS 
    The different extracts were separately dissolve in alcohol solution and then subjected 
to the following test. 
 
a) Shinoda’s Test: 
To the alcoholic solution a small piece of magnesium metal followed by 
concentrated hydrochloric acid was added drop wise and heated. Magenta colour 
was produced in Ethanol, chloroform and aqueous extracts indicating the presence of 
flavonoids. 
 
    b) Ferric chloride Test 
 To the alcoholic solution few drops of neutral Ferric chloride solution was added. 
Blackish red precipitate was observed in Ethanol, chloroform and aqueous extracts 
indicating the presence of flavonoids. 
 
DETECTION OF FLAVONES 
 
a) With sodium hydroxide solutions the extracts gave yellow colour. 
 
b) With concentrated sulphuric acid orange colour was produced. 
 
c) ZINC, HYDROCHLORIC ACID REDUCTION TEST 
To a small quantity of each extracts a pinch of Zinc dust was added. Then added a few 
drops Con.Hydrochloric acid. Magenta colour was produced. 
 
d) LEAD ACETATE SOLUTION TEST 
To a small quantity of each extracts a few drops of 10% lead acetate solution was 
added Yellow precipitate was produced indicating the presence of flavones in all the 
extracts. 
DETECTION OF COUMARINS 
a) The small quantity of extracts were dissolved in alcohol and exposed to U.V light. It 
produce green colour. 
b) All the extracts were dissolved in alcohol and added with few drops of Ferric 
chloride solution green colour was obtained. 
K.M.College	of	Pharmacy,	Madurai	 Page	31	
 
All the extracts showed the presence of coumarins. 
DATA SHOWING THE PRELIMINARY PHYTOCHEMICAL SCREENING OF THE 
VARIOUS EXTRACTS OF Crataeva magna Lour DC 
 









Carbohydrates - + + 
Glycosides + + + 
Alkaloids + + + 
Phytosterols - + + 
Saponins + + + 
Fixed oils & fat + + + 
Tannins + + - 
Protein & Amino 
Acids + + - 
Flavonoids - + + 
Coumarins + + + 
Flavones + + + 
 
       +  - Indicate positive test results 
 
- - Indicate negative test results 
 







BEHAVIOUR OF POWDER 
 
Coarsely powdered root bark of Crataeva magna Lour DC was treated with various 
reagents and observed and shown in the Table No.2. 
 
TABLE NO.2 
REAGENTS COLOUR/PPT CONSTITUENTS 
Powder as such Brownish Green - 
Powder+ conc. Sulphuric 
acid 
Brown colour Steroids present 
Powder+Aqs Ferric 
Chloride 
No Black colour Tannins absent 
Powder+ Iodine Sol. No Blue colour No Starch Present 
Powder+ Aqs. Mercuric 
Chloride 





Powder+Mg.HCL Light Yellow colour Flavonoids Present 
Powder+ Ammonia Reddish Brown 
Anthraquinone 
Present 
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ISOLATION, PURIFICATION AND IDENTIFICATION OF THE  
CONSTITUENTS OF Crataeva magna Lour DC  
 
COLUMN CHROMATOGRAPHY OF ETHANOLIC EXTRACT43 
10 gm of crude ethanolic extract was packed with 100 gms of silica gel (60-120) mesh 
using 2.4 diameter column was packed with mixture of ethyl acetate and hexane. The column 
was eluted with increasing solvent polarity from hexane to ethyl acetate.  
 
PREPARATION OF COLUMN 
 The glass column of 3 cm diameter was packed with activated silica gel                   
(100 – 120 mesh) slurry in petroleum ether to a height of 45 cm in order to establish a column 
of 300 ml. The column was developed according to the following lines. The column was built 
up by passing one-column volume of petroleum ether before the residue was loaded. The 
solvent was kept 5 cm above the bed and the residue was carefully loaded in the form of 
petroleum ether slurry. The column was then developed with a series of solvent starting with 
Petroleum Ether, Hexane, Ethyl Acetate and Methanol in increasing polarity. 
 
 The different ratios with succeeding solvents were fixed and are shown in the table no 
2. Fractions of 100 ml were collected up to methanol system and thereafter, fraction in 

















PREPARATION OF THIN LAYER CHROMATOGRAPHY PLATES44 
 
About 50 gm silica gel G was weighed and it was shaken with 100 ml water to form a 
homogenous suspension. This suspension was poured into a thin layer chromatography 
applicator, which was adjusted to 0.25 mm thickness.      
 
The plates were kept in hot air oven at 110 C for 1 hour to activate the silica gel G. 
They were then stored in dry atmosphere and used when ever required. 
 
By using the capillary tube, the elutes were spotted on the TLC plates around 2 cm 
above its bottom and subjected to chromatogram with different solvent systems. The 
compounds moved according to their affinity towards different solvent system. 
 
The plates after development in each solvent system were observed under UV lamp. 
The different spots developed in each solvent systems were identified and by means of 
different spraying systems and also by placing in iodine chamber. The compounds moved 
relative to their affinity. 
 
R f = 
Distance travelled by solute 

















DATA SHOWING VARIOUS CONSTITUENTS PRESENT IN THE 
EXTRACTS BY THIN LAYER CHROMATOGRAPHY 
 




Mobile Phase Spraying Reagent Inference 
1 Alkaloids 
Methanol : Ammonium 
Hydroxide              
5 : 5 
Dragendorff reagent 





Ethyl Acetate : Hexane    
3 : 7 
Anisaldehyde 
sulphuric Acid 
Orange Brown  
Rf  =0.6;0.7 
3 Flavonoids 
Butanol : Acetic Acid 
:Water : Ether           




 Rf =0.46;0.52 
4 Phytosterols 
Hexane : Diethyl Ether    
32 : 1 
Stannic Chloride 
Orange Brown  
Rf =0.6;0.54 
5 Carbohydrates 
Butanol : Acetic Acid 
:Water : Ether           




 Rf =0.52;0.63 
6 Tannins 
Toluene : Acetone       
9 : 1 
Ferric Chloride 
Black observed  















DATA SHOWING THE COLUMN CHROMATOGRAPHY OF ETHANOLIC EXTRACT 
         









1 1-50 98%Hex:2%Etoac 600  
2 51-90 95%Hex:5%Etoac 500  
3 91-120 90%Hex:10%Etoac 500  
4 121-160 85%Hex:15%Etoac 600  
5 161-180 80%Hex:20%Etoac 800 Compound 
1 
6 181-200 75%Hex:25%Etoac 800  
7 201-220 100%Etoac 400  
8 221-238 98%Etoac:2%MeoH 350 Compound 
2 
9 239-250 90%Etoac:10%MeoH 250  
 



















                                                              TABLE NO.5 
 
FRACTIONS ELUTES SYSTEM Rf VALUES 
 CM  I BENZENE: CHLOROFORM (8:2) 0.42 
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            IDENTIFICATION OF ISOLATED COMPOUNDS45-47 
 
COMPOUND CM– I 
The compound was isolated from the dried root bark of Crataeva magna Lour DC 
   
Appearance                              :   Dark Green residue 
Yield Obtained          :   120 mg 
Solubility           :   Soluble in Benzene and chloroform 
Melting point          : 142 ◦ C  
 
CHEMICAL TEST 
TEST FOR ALKALOIDS 
1. Mayer’s Test 
         A small quantity of compound CM-I was mixed with dil. HCL and to this one-drop of 
Mayer’s reagent (Postassium mercuric iodide) was added. It produced a precipitate, 
indicating the presence of alkaloids. 
  
2.  Dragendorff’s Test 
   A small quantity of compound CM-I was mixed with dilute HCL, followed by 1 ml of 
dragendorff’s reagent (Postassium bismuth iodide). An orange red precipitate was formed. 
 
3. Wagner’s Test 
        A small quantity of compound CM-I was mixed with 1 ml of dil. HCL followed by 1ml 
of Wagner’s reagent (Iodide solution) a brown precipitate was produced. 
 
4. Hager’s Test 
         A small quantity of compound CM-1 was mixed with 1ml of dil. HCL, follwed by 1 ml 









       Benzene                : Chloroform (8:2) 
       Rf                          : 0.42 
      Spraying Reagent  : Dragendorff  Reagent, Iodine chamber 
 
IR SPECTRUM OF COMPOUND CM-1 
         IR Spectrum was taken using neat on Perkin Elmer model IR spectrophotometer, KBr- 
media. The spectrum was attached. The IR peak and the groups assigned are shown in           
Table No:6 
 
NMR SPECTRA OF COMPOUND CM-1 
 
        NMR was taken on Avance 300, 1HNMR (CDCl3) 300 MHz, TMS as standard as shown in 
the Table No. 7 and the spectrum were attached.   
 
                                                             
                                                                     TABLE NO.6 
 
COMPOUND CM I 
 
S.No 
Frequency Groups Assigned 
 (cm-1) 
1 3392.55 May be due to O-H  stretching 
2 2364.57 May be due to C-H  stretching 
3 1741.60 May be due to C=O stretching 
4 1697.24 May be due to C=O stretching 
5 1498.59           May be due to C-H  bending 
6 1461.94           May be due to C-H  bending 
7 1222.79           May be due to C-O  stretching 
8 1163 May be due to C-O  stretching 











                                                                  TABLE NO.7 
 
S.No SIGNALS (δ ) VALUES ppm GROUPS ASSIGNED 
1 0.745 Due to CH3 protons 
2 0.929 Due to CH3 protons 
3 1.034 Due to CH3 protons 
4 1.137-1.515 Due to CH3 protons 
5 1.807-1.957 Due to CH protons 
6 2.13 Due to CH2 proton attached near to CH2-C=O 














































































COMPOUND CM – II 
 
The compound was isolated from the dried root bark of Crataeva magna Lour DC. 
 
Appearance                              :    Green 
Yield Obtained     :    90 mg 
Solubility     :    Soluble in Benzene and chloroform 
Melting point           :    138C  
 
CHEMICAL TEST 
TEST FOR GLYCOSIDES 
 
Small quantity of the compound CM II   were hydrolyzed with hydrochloric acid for two 
hours on a water bath and the hydrolysate was subjected to 
 
a) Legal’s  b) Borntrager’s and c) Modified Borntrager’s  test to detect the presence of different 
glycosides. 
 
a) Legal’s Test: 
    To the hydrolysate, 1 ml of pyridine and few drops of sodium nitroprusside solution 
were added then it was made alkaline with sodium hydroxide solution. Appearance of pink 
to yellow colour was observed; it showed the presence of glycosides  
 
b) Borntrager’s Test: 
    Hydrlosate was treated with chloroform and chloroform layer was separated. To this 
equal quantity of dilute ammonia solution was added. Appearance of pink colour was 
observed in ammoniacal layer. 
 
 
c) Modified Borntrager’s Test: 
  The hydroslate compound was boiled with few ml of dilute hydrochloric acid and    5 
ml of ferric chloride solution. The contents are cooled and shaken with organic solvents. 
Organic layer was separated and to this equal volume of ammoniacal solution was added. 
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The ammoniacal layer showed pink colour. In this test, addition of ferric chloride was added 
to break the C-C linking of glycosides which is stronger than C=O linkage. 
 
TLC SYSTEM: 
           Chloroform : Ethyl Acetate (7:3) 
           Rf                         : 0.71 
 
IR SPECTRUM OF COMPOUND CM-II 
IR Spectrum was taken using neat on Perkin Elmer model IR 
spectrophotometer         (KBr) Media. The spectrum was attached. The IR peak and the 
groups assigned are shown in Table No:8 
 
NMR SPECTRA OF COMPOUND CM-II 
      NMR was taken on Avance 300, 1HNMR (CDCl3) 300 MHz, TMS as standard 























                                                             TABLE NO. 8 
 
                                                       Compound - CM II 
 





1 3392.55 May be due to O-H stretching 
2 2362.64 May be due to C-H stretching 
3 1622.02 May be due to C=O stretching 
4 1544.88 May be due to N-H bending 
5 1375.15 May be due to C-H bending 
6 1222.79 May be due to C-O stretching 
7 1163 May be due to C-O stretching 
8 1033.77 May be due to C-O stretching 
9 723.26 May be due to C-H bending 


















                                                         TABLE NO.9 
 
S.No 




1 0.979 Due to CH3 protons 
2 1.2 Due to CH3 protons 
3 1.96 Due to CH2 attached  to C =C 























































                                                                  



















































ANTI CANCER ACTIVITY OF ETHANOLIC EXTRACT OF 
CRATAVEVA MAGNA LOUR DC AGAINST DALTON’S ASCITIC 




Selection Grouping and Acclimatization of Laboratory Animal 48 
Male Swiss albino mice (20-25 gm) were produced from animal experimental 
laboratory, and used throughout the study. They were housed in micro nylon boxes in a 
control environment (temp 25±2°C) and 12 hrs dark /light cycle with standard laboratory diet 
and water ad libitum. The study was conducted after obtaining institutional animal ethical 
committee clearance. As per the standard practice, the mice were segregated based on their 
gender and quarantined for 15 days before the commencement of the experiment. They were 
fed on healthy diet and maintained in hygienic environment in our animal house. 
Technique for Inducing Tumor  
Various technique for induction of cancer in animals, viz, chemically induced (using 
DMBA/croton oil, etc) [49] virus induced, cell line induced (sarcoma – 180, ULCA fibro 
sarcoma and Jensen sarcoma, mouse lung fibroblast cells L-929, Dalton’s Ascites Lymphoma  
(DAL), Ehrlich Ascites Carcinoma (EAC)50-52 methods have been used in experimental 
studies of anticancer activity. 
 In the present study, cell lines induced cancer in mice was used to evaluate the 
anticancer activity of ethanolic extract of cratavea magna lour DC.  
EVALUATION OF ANTICANCER ACTIVITY 
Induction of cancer using DAL cells 
Dalton’s Ascites Lymphoma (DAL) cells were supplied by Amala cancer research 
center, Trissur, Kerala, India. The cells maintained in vivo in Swiss albino mice by 
intraperitoneal transplantation. While transforming the tumor cells to the grouped animal the 
DAL cells were aspirated from peritoneal cavity of the mice using saline. The cell counts 
were done and further dilution were made so that total cell should be 1 x 106, this dilution 
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was given intraperitonealy. Let the tumour grow in the mice for minimum seven days before 
starting treatments.  
Treatment Protocol    
Swiss Albino mice were divided in to five group of six each. All the animals in four  
groups were injected with DAL cells (1 x 106 cells per mouse) intraperitoneally, and the 
remaining one group is normal control group. 
 Group 1 served as the normal control.  
 Group 2 served as the tumour control. Group 1 and 2 receives normal diet and Water.   
 Group 3 served as the positive control, was treated with injection 5- fluorouracil at 20mg/kg 
body weight, Intra peritoneally.53 
Group-4 served as treatment control received 200 mg/kg EECM administered through  
orally. 
Group-5 served as treatment control received 400 mg/kg of EECM administered through 
orally. 
Treatment 
 In this study, drug treatment was given after the 24 hrs of inoculation, once daily for 
14 days. 
 On day 14, after the last dose, all mice from each group were sacrificed by euthanasia.  
Blood was withdrawn from each mouse by retro orbital puncture bleeding and the following 
parameters were checked.   
      1.      Hematological parameters 
a. WBC count   
b. RBC count  
c. Hb  content 
d. Platelet count 




2.   Serum enzyme and lipid profile 
a. Total Cholesterol                    (TC) 
b. Triglycerides                          (TG) 
c. Aspartate amino Transferase  (AST) 
d. Alanine amino Transferase    (ALT) 
e. Alkaline Phosphatase             (ALP) 
     
     3.     Derived parameter 
a.   Body weight 
                  b.   Life span (%) 
                  c.  Cancer Cell Count 
 
EVALUATION OF CLINICAL PARAMETERS  
Cancer cell count 54 
The fluid (0.1ml) from the peritoneal cavity of each mouse was withdrawn by sterile 
syringe and diluted with 0.8 ml of ice cold Normal saline or sterile Phosphate Buffer Solution 
and 0.1 ml of tryphan blue (0.1 mg/ml) and total numbers of the living cells were counted 
using heamocytometer. 
                              No of cells dilution 
   Cell count = ------------------------------------------              
                        Area × Thickness of liquid film 
1) Hematological parameters 
i) WBC count 
ii) RBC count 
iii) Platelet count 
iv) Hemoglobin 




i) WBC count 
 The total WBC count was found to be increased in cancer control, when compared 
with normal and treated tumor-bearing mice.55 
ii) RBC and Hb 
 RBC and Hb content decreases with tumor bearing mice when compared with Normal 
control mice. 
iii) Platelets 
 In Hodgkin lymphoma, increased in platelet count often reported in laboratory 
finding. Hence, I investigated this parameter in the study. 56 
iv) Packed cell volume  
           In any case of anemia the packed cell volume is decreases.  
SERUM ENZYME AND LIPID PROFILE 
The serum was analyzed for the following parameters 
(a) Aspartate amino Transferase (AST) 
(b) Alanine amino Transferase    (ALT) 
(c) Alkaline Phosphatase             (ALP) 
(d) Total Cholesterol                    (TC) 
(e) Triglyceride                            (TG) 
 
1. TOTAL CHOLESTEROL AND TRIGLYCERIDE (lipid profile) 
 Abnormal blood lipid profile has been associated with cancer. In Hodgkin lymphoma, 
high cholesterol level and low triglyceride level has been reported. Hence I investigated this 
parameter in the study. 57 
LIVER ENZYMES (AST, ALT and ALP) 
 Abnormal liver function seen in patient with Hodgkin lymphoma, that these liver 
enzyme levels markedly increase in tumor bearing mice. ALP is an enzyme mainly derived 
from the liver, bones and in lesser amount from intestines, placenta, kidneys and leukocytes. 
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An increase in ALP levels in the serum is frequently associated with the variety of disease.58 
ALP comprises a group of enzyme that catalyzes the phosphate esters in an alkaline 
environment, generating an organic radical and inorganic phosphate. 
 Markedly elevated serum ALP, hyperalakline-phosphatasemia, is seen predominantly 
with more specific disorders; including malignant biliary cirrhosis, hepatic lymphoma and 
sarcoidosis. 59 Hence, I investigated this parameter in this study. 
 
DERIVED PARAMETERS 
1. Body weight: 
   All the mice were weighed, from the beginning to 15th day of the study. Average 
increase in body weight on the 15th day was determined. 
2. Percentage increase in life span (ILS)  
 % ILS was calculated by the following formulae 
   Life span of treated group 
 %ILS = 100x1
groupcontrolofspanLife
grouptreatedofspanLife      
 All biochemical investigations were done by using COBAS MIRA PLUS-S 
Auto analyzer from Roche Switzerland. 
 Hematological test are carried out in COBAS MICROS OT 18 from Roche. 
 Newly added Hi-Tech instruments MAX MAT used for an auto analyzer for 








                                                     Table No. 1 
Effect of EECM on Haematological Parameters 
 
G1 – Normal Control, G2 – Cancer Control, G3 – Positive control, G4 – Treatment control 
200mg/kg EECM, G5 – Treatment control 400 mg/kg EECM 
All values are expressed as mean ± SEM for 6 animals in each group. 
**a – Values are significantly different from control (G1) at P < 0.01 
















PCV % Platelets 
Lakhs/cumm
G1 13.85 ±1.80 5.60±0.86 13.65 ±1.30 16.40±2.45 5.46±0.90 
G2 15.65 ±2.60a** 4.48±0.20a** 8.36  ±0.92a** 32.40±3.25a** 3.75±0.62a**
G3 12.60 ±1.75b** 5.20±0.78b** 12.30±1.45b** 18.40±1.50b** 4.80±0.96b**
G4 11.42 ±1.90b** 5.45±0.58b** 11.40±1.32b** 22.40±1.70b** 4.15 ±0.80b**




                                                  Table No.2 
Effect of EECM on serum Enzymes and lipid proteins 
 
G1 – Normal Control, G2 – Cancer Control, G3 – Positive control, G4 – Treatment control 200 
mg/kg EECM, G5 – Treatment control 400 mg/kg EECM) 
All values are expressed as mean ± SEM for 6 animals in each group. 
**a – Values are significantly different from control (G1) at P < 0.01 


















G1    125.30±3.70    138.60±2.55 43.65 ±1.35 34.50 ±1.55   121.40 ±2.45 
G2 154.90±4.65a** 223.40±4.85a** 89.6±2.70a** 64.45±2.70a** 230.45±4.36a**
G3 132.50±3.90b** 168.65±2.45b** 56.48 ±1.85b** 45.50±1.85b** 169.45±2.55b**
G4 134.55±4.15b** 172.30±2.85b** 64.50±1.95b** 47.36 ±1.98b** 188.65±2.70b**
G5 134.50±3.25b** 171.60±2.60b** 62.65 ±2.35b** 46.30±1.75b** 188.42±2.35b**
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                                                         Table No.3 
Effect of EECM on the life span, body weight and  
Cancer cell count of tumor induced mice 
 
 









ml X 106 
G1 6 >>31 days   1.70±0.62 - 
G2       6 49% 6.80±0.96a** 3.70±0.40a** 
G3 6 92% 4.85±0.70b** 2.59±0.22b** 
G4 6 88% 5.55±0.88b** 2.80±0.30b** 
G5 6 87% 5.70±0.86b** 2.78±0.25b** 
 
G1 – Normal Control, G2 – Cancer Control, G3 – Positive control, G4 – Treatment control 
200mg/kg EECM, G5 – Treatment control 400 mg/kg EECM 
All values are expressed as mean ± SEM for 6 animals in each group. 
**a – Values are significantly different from control (G1) at P < 0.01 










Figure No. 1 
Normal Control Group 
  
Section shows Structure of Liver with sheets of Hepatocytes Separated by 










Figure No. 2 
Toxic control group (Tumour Control) 
 
 
Sections shows structure of liver with cords of hepatocytes and 













Positive control, was treated with injection fluorouracil at 
20 mg/kg body weight, Intra peritoneally 










Figure No .4 
(Treatment Control) 
Treatment control received 200 mg/kg of EECM administered through orally 
 
 
Section show structure of liver with cords of hepatocytes. 










Figure No. 5 
(Treatment Control) 
Treatment control received 400 mg/kg of EECM administered through orally 
 
 
Sections show liver parenchyma with cords of hepatocytes. 


























                                                   RESULTS & DISCUSSION 
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RESULTS & DISCUSSION 
For the sole reason that Crataeva magna Lour DC possess various phytoconstituents 
and pharmacological properties, we resolved to work on root bark of Crataeva magna Lour 
DC, which are widely used in medicines of natural products. 
 
The root bark was shade-dried and ground to coarse powder and extracted in series, 
using Petroleum ether AR, Chloroform AR and Ethanol AR in an increasing order of polarity  
 
Phytochemical Screening of Crataeva magna Lour DC was undertaken to study, 
isolate and characterize the chemical constituents and the Pharmacological activities. 
 
During our investigation, the Pet ether extract, chloroform extract, Ethanol extract 
have revealed the presence of Glycosides, Alkaloids, Carbohydrates, Phytosterols, Saponins, 
Fixed oils, Fats, Flavonoids and Coumarins  and these constituents were isolated extraction 
with Chloroform AR. 
 
The Ethanol extract was subjected to Column Chromatography on silica (100-200) 
mesh. During our investigation about two Compounds were isolated. 
                                                      
                                                          CM-I & CM-II 
 
These compounds eluted with solvents of increasing polarity like Petroleum ether,  
Chloroform, Ethyl acetate and methanol. In the course of isolation procedure, the above 
named 2 compounds were further processed and characterised. 
 
The compound CM-I is Dark green semisolid in appearance. In TLC, it showed a 
single spot using Benzene: Chloroform (8:2) have Rf value 0.42 and the melting point is 
142C. The IR & 1H NMR Spectral data showed the characteristic feature of Alkaloids and 






The compound CM-II is green viscous in appearance. In TLC, it showed a single spot, 
using chloroform: Ethyl Acetate (7:3) have Rf value 0.71 and the melting point is 138C. The 
IR & 1H NMR Spectral data showed the characteristic feature of Glycosides and which was 
also confirmed by chemical test. 
 
Effect on Tumour Growth  
 In the DAL tumour control group, the average life span of animal was found to be 
49% where as EECM at a dose of 200 mg and 400 mg/kg body weight increase the life span 
to 88%, and 87% respectively. These values were significant. However the average life span 
of 5- FU treatment was found to be 92%, indicating its potent antitumor nature. The 
antitumor nature of Cratavea magna Lour DC were evidenced by the significant reduction in 
percent increase in body weight of animal treated with Cratavea magna Lour DC when 
compared to DAL tumour bearing mice.  
 It was also supported by the significant reduction in packed cell volume and viable 
Tumour cell count in EECM at a dose of 200mg and 400/kg body weight treatments when 
compared to the DAL tumour control. (Table No 2 & 3).   
Effect on Hematological Parameters 
 As shown in (Table No.1) RBC, Hgb, Platelets were decreased and WBC count was 
significantly increased in the DAL control group compared to the normal control group. 
Treatment with Cratavea magna Lour DC significantly increases the Hb content, RBC, 
Platelets and significantly decreased the WBC count to about normal level. All these results 
suggest the anticancer nature of the Cratavea magna Lour DC. However, the standard 5-FU 
at the dose of 20 mg/kg body weight produced better result in all these parameters. 
Effect on Biochemical Parameters 
 The inoculation of DAL cells caused significantly increase in the level of Total 
Cholesterol, Aspartate amino Transferase, Alanine amino Transferase, Alkaline Phosphatase 
in the tumor control animals (G2), when compared to the normal group. The treatment with 
Cratavea magna Lour DC weight reversed these changes towards the normal level. (Table 




    The alternative system of medicines like Ayurvedic, Siddha, Unani and other tribal 
folklore medicines have significantly contributed to the health care of the population of India. 
Today these systems are not only complementary but also competitive in the treatment of 
various diseases. Plants have served as a good source of antitumor agents. Several studies 
have been conducted an herbs under a multitude of ethanol botanical grounds. A large 
number of plants possessing anticancer properties have been documented. 
                 Plants of ethanolic extract of Crataeva magna Lour DC was traditionally used in 
the treatment of tumors. The present investigation was carried out to evaluate the antitumor 
activity of ethanolic extract of Crataeva magna Lour DC in DAL tumor bearing mice. The 
ethanolic extract of Crataeva magna Lour DC treated animals at the doses of 200&400 
mg/kg significantly inhibited the tumor volume, packed cell volume, tumor (viable) cell 
count and brought back the haematological parameters to more or less normal levels. 
                  In DAL tumor bearing, a regular rapid increase in ascitic tumor volume was 
observed. Ascitic fluid is the direct nutritional source for tumor cells and a rapid increase in 
ascitic fluid with tumor growth would be a means to meet the nutritional requirement of 
tumor cells. Treatment with Cratavea magna Lour DC inhibited the tumor volume, viable 
tumor cell count and increased the life span of the tumor bearing mice. The reliable criteria 
for judging the value of any anticancer drug are the prolongation of the lifespan of animals. It 
may be concluded that by decreasing the nutritional fluid volume and arresting the tumor 
growth increases the life span of DAL bearing mice. Thus Cratavea magna Lour DC at a 
dose of 200 mg and 400 mg/kg body weight have antitumor activity against DAL bearing 
mice. 
             Usually, in cancer chemotherapy the major problems that are being encountered are 
of myelo suppression and anemia. The anemia encountered in tumor bearing mice is mainly 
due to reduction in RBC or hemoglobin percentage and this may occur either due to iron 
deficiency or due to hemolytic or myelopathic conditions. Treatment with Ethanolic extract 
of Cratavea magna Lour DC  brought back the hemoglobin (Hb) content, RBC and WBC 
count more or less to normal levels significantly. This clearly indicates Ethanolic extract of 
Cratavea magna Lour DC possess protective action on the haemopoietic system. 
           It was reported that the presence of tumour in the human body or in the experimental 
animals is known to affect may function of the liver. The significantly elevated level of total 
cholesterol, TG, AST, ALT and ALP in serum of tumour inoculated animal indicated liver 
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damage and loss of functional integrity of cell membrane. The significant reversal of these 
changes towards the normal by Ethanolic extract of Cratavea magna Lour DC treatments. 
            In the present study, the biochemical examination of DAL inoculated animals showed 
marked changes indicating the toxic effect of the tumour. The normalization of these effects 
observed in the serum treated Ethanolic extract of Cratavea magna Lour DC weight 
supported the potent antitumor and hepatoprotective effect of the  Ethanolic extract of 











































                                         CONCLUSION 
 
 






              As is evident from our experiments that Phytoconstituents present in these extracts 
are too many, it is decided to further up our exercise to isolate and characterize each and 
individual compound. During our course of Pharmacological activates both Ethanolic and 
Aqueous extracts, when compared to standard showed almost equipotent significance in 
respect of the protocol studies.  
             As on date, special care and attention has been converged on the Phytochemical and 
Degradation studies and the role and importance of natural products of medicinal interest. 
Nowadays the research on main source of novel-lead substances for drug design and 
modeling. The natural and synthetic Phytoconstituents constitute a prime and vital role in 
Pharmacological, Clinical and Cytotoxic studies leading to an important impact in preparing 
natural-product-based libraries for Combinatorial Chemistry. 
            Eventually, a sociology of this extent, provide a constructive basis upon which 
verified and detailed investigations of various parameters on therapeutic efficacy of natural 
products leading to excellent use of indigenous medicine is achieved. 
In the conclusion, Crataeva magna Lour DC was selected for the present study based 
on its traditional claim. The Ethanolic extract of Crataeva magna Lour DC possess 
significant anti cancer activity against DAL and EAC induced in mice. This herb was 
effective in inhibiting the tumour growth in ascitic and solid tumour models. The biochemical 
and histopathological studies also supported its antitumor properties. However, further 
researches are required to isolate and identify the active constituents for anti cancer agents 
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